Korro Bio, Inc. (KRRO)

11.61 +0.41 (+3.66%) USD  |  NASDAQ  |  May 22, 16:00
11.66 +0.05 (+0.43%) After-Hours: 20:00
More

Korro Bio EPS Diluted (Quarterly) : -1.692 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for KRRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
United Therapeutics Corp. 5.824
ProKidney Corp. -0.1412
ACADIA Pharmaceuticals, Inc. 0.0211
Agenus, Inc. 1.023
Alnylam Pharmaceuticals, Inc. 1.508

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -19.62M
Total Expenses (Quarterly) 19.62M
Enterprise Value 95.36M
Earnings Yield -100.6%
Normalized Earnings Yield -78.48